Florida Healthcare
Compliance Guide

Florida presents a dynamic and generally favorable regulatory environment for healthcare companies, particularly those leveraging telehealth. The state has historically adopted a pro-business stance, which extends to healthcare innovation, though it maintains robust consumer protection mechanisms. Key regulatory bodies include the Florida Department of Health (DOH), which oversees various professional boards like the Board of Medicine, Board of Osteopathic Medicine, Board of Nursing, and Board of Pharmacy. These boards are responsible for licensing, disciplinary actions, and interpreting practice acts. Florida has been proactive in codifying telehealth regulations, establishing a clear framework for its use and reimbursement. Recent legislative actions, such as the continued support for telehealth expansion and efforts to streamline professional licensing, underscore the state's commitment to increasing access to care. However, this pro-innovation approach is balanced by strict enforcement of the Corporate Practice of Medicine (CPOM) doctrine and controlled substance prescribing rules. Companies must navigate these complexities carefully, ensuring their business models, provider relationships, and service delivery methods comply with Florida's specific statutes and administrative codes. The state's large and growing population, coupled with its status as a major tourism destination, makes it an attractive market, but also one where compliance vigilance is paramount. Understanding the nuances of CPOM, telehealth modalities, prescribing limitations, and scope of practice for various professionals is critical for successful and compliant operations in the Sunshine State. The general business climate encourages growth, but only within the bounds of a well-defined regulatory framework designed to protect patient safety and the integrity of the medical profession.

Florida maintains a strict Corporate Practice of Medicine (CPOM) doctrine, which generally prohibits corporations, entities, or laypersons from practicing medicine or employing physicians to practice medicine. The legal basis for Florida's CPOM doctrine is primarily derived from case law and the interpretation of the Medical Practice Act, specifically Florida Statutes Chapter 458 (Medical Practice) and Chapter 459 (Osteopathic Medicine). While there isn't a single, explicit CPOM statute, the Florida Board of Medicine and Florida courts have consistently held that only licensed physicians or professional corporations/partnerships owned and controlled by licensed physicians may practice medicine. This means:

• Ownership Structures: Non-physicians cannot own entities that directly provide medical services. This extends to entities that employ physicians, set physician compensation, control medical decision-making, or receive fees for medical services.
• Permitted Structures: The most common compliant structure involves a Professional Association (PA) or Professional Limited Liability Company (PLLC) owned by one or more Florida-licensed physicians. This professional entity then contracts with a Management Services Organization (MSO) for administrative, non-clinical services.
• Non-Physician Ownership: Non-physicians cannot own a medical practice. This includes corporations, private equity firms, or individuals who are not licensed physicians.
• Specific Restrictions: The CPOM doctrine restricts lay entities from:
  • Employing physicians to provide medical services.
  • Controlling the professional judgment of physicians.
  • Splitting professional fees with non-licensed individuals or entities (fee-splitting).
  • Holding themselves out as providing medical services.

Impact on Telehealth Companies: Telehealth companies must structure themselves carefully. Typically, a Florida-licensed physician or physician-owned professional entity provides the medical services (e.g., diagnosis, treatment, prescribing), while a separate MSO provides the technology platform, marketing, billing, and other administrative support. The MSO cannot direct clinical care or employ the physicians.

Medspas, Dental Practices, and Wellness Clinics: These entities are also subject to CPOM.

• Medspas: If services involve medical procedures (e.g., injectables, laser treatments, certain IV therapies), they must be performed under the supervision or direction of a Florida-licensed physician, and the medical component of the business must be owned by a physician. Non-physicians can own the 'spa' or 'wellness' component that provides non-medical services, but cannot own the medical practice itself.
• Dental Practices: Florida has a specific Dental Practice Act (Chapter 466, F.S.) that similarly restricts ownership to licensed dentists.
• Chiropractic Practices: Chapter 460, F.S., governs chiropractic medicine, with similar ownership restrictions.
• IV Therapy Clinics: If IV therapy involves prescription medications or medical diagnosis, it falls under the practice of medicine and must adhere to CPOM.

Enforcement: The Florida Board of Medicine actively investigates and prosecutes violations of CPOM, often in conjunction with fee-splitting prohibitions. Companies must ensure their MSO agreements are carefully drafted to avoid any perception of control over clinical decision-making or improper financial arrangements.

Florida has established a robust framework for telehealth, primarily codified in Florida Statutes § 456.47 and various professional board rules. The state generally supports the use of telehealth to expand access to care, provided it meets the same standard of care as in-person services.

• Establishment of Provider-Patient Relationship: A provider-patient relationship can be established via telehealth in Florida. The law states that a healthcare practitioner may use telehealth to conduct a patient evaluation and establish a diagnosis, provided the practitioner acts within their scope of practice and the prevailing standard of care. This means an initial in-person visit is generally not required to establish a relationship for telehealth services, though specific circumstances or professional judgment may dictate otherwise.

• Permitted Modalities: Florida law permits various modalities for telehealth, including:

  • Synchronous Telehealth: Real-time, interactive audio-visual communication. This is the preferred method for establishing a new patient relationship and for complex medical encounters.
  • Asynchronous Telehealth (Store-and-Forward): Transmission of recorded health information (e.g., images, videos, data) to a practitioner for evaluation. This is permissible when appropriate for the condition being treated and consistent with the standard of care.
  • Audio-Only Telehealth: While synchronous audio-visual is generally preferred, audio-only telephone calls may be used for telehealth services if the practitioner determines that such a modality is appropriate to meet the patient’s health care needs and is consistent with the prevailing standard of care. However, for establishing new patient relationships or for prescribing controlled substances, audio-visual is often explicitly or implicitly required or strongly recommended.

• Telehealth Registration Requirements: Healthcare practitioners providing telehealth services to patients located in Florida must be licensed in Florida. There is no separate 'telehealth registration' per se for individual practitioners beyond their professional licensure. However, out-of-state practitioners who wish to provide telehealth services to Florida patients must register with the Florida Department of Health as an 'out-of-state telehealth provider' under Florida Statutes § 456.47(1)(c). This registration requires holding an active, unencumbered license in another state and submitting an application, fees, and background information.

• Informed Consent Requirements: Prior to providing telehealth services, practitioners must obtain informed consent from the patient. This consent must include, at a minimum:

  • Identification of the healthcare practitioner and their license.
  • Confirmation that the patient understands the services provided via telehealth.
  • Information on how to contact the practitioner for follow-up care.
  • Acknowledgement of the risks and benefits of telehealth.
  • Privacy practices related to telehealth.

• Geographic Restrictions: There are no specific geographic restrictions within Florida for telehealth services, meaning a licensed Florida practitioner can provide telehealth to a patient anywhere within the state. However, the patient must be physically located in Florida at the time of the telehealth encounter for the Florida license to be applicable.

Florida maintains stringent rules regarding the prescribing of controlled substances via telehealth, particularly under Florida Statutes § 456.47 and Board of Medicine Rule 64B8-9.013, F.A.C. These rules align with federal DEA requirements but often add state-specific nuances.

• Schedules Prescribable via Telehealth:

  • Schedule II Controlled Substances: Generally, Schedule II controlled substances cannot be prescribed via telehealth unless specific exceptions apply. These exceptions include:
    • Treatment of a psychiatric disorder.
    • Inpatient treatment at a hospital.
    • Treatment of a patient receiving hospice services.
    • Treatment of a patient residing in a nursing home facility.
    • Crucially, for all other Schedule II prescriptions, an in-person examination is required before the initial prescription. Subsequent prescriptions may be issued via telehealth if the practitioner has established a legitimate medical purpose and a valid patient-practitioner relationship through an initial in-person visit.
  • Schedule III-V Controlled Substances: These can generally be prescribed via telehealth, provided a legitimate medical purpose exists, a valid patient-practitioner relationship has been established, and the prescribing aligns with the prevailing standard of care. An initial in-person exam is not strictly required for these schedules, but an appropriate telehealth evaluation (typically synchronous audio-visual) is necessary.

• DEA Requirements: Florida's rules largely mirror federal DEA requirements regarding telehealth prescribing. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation before prescribing controlled substances via the internet. While the COVID-19 public health emergency (PHE) waivers allowed for greater flexibility, these waivers have largely expired. Practitioners must adhere to the 'telemedicine exception' criteria, which typically involves a prior in-person examination or the prescription being issued by a practitioner who is acting in the usual course of professional practice and who has conducted a legitimate medical evaluation. The DEA is currently in the process of finalizing new permanent rules for telehealth prescribing of controlled substances, which may impact these requirements.

• PDMP Checking (E-FORCSE): Florida mandates that practitioners consult the Prescription Drug Monitoring Program (PDMP), known as E-FORCSE (Florida's Prescription Drug Monitoring Program), before prescribing or dispensing Schedule II, III, or IV controlled substances. This check must occur each time a controlled substance is prescribed or dispensed, unless specific exceptions apply (e.g., patients in hospice, nursing homes, or emergency situations where delaying treatment would harm the patient). Failure to check the PDMP can result in disciplinary action.

• Quantity or Refill Limitations: Florida law imposes specific quantity limits on opioid prescriptions for acute pain, generally limited to a 3-day supply, with exceptions for a 7-day supply if documented as medically necessary. Similar limitations may apply to other controlled substances based on professional board rules or specific drug classes. Refills for controlled substances are subject to federal and state regulations, often requiring a new prescription after a certain period or number of refills.

• Special Rules for Specific Drug Classes:

  • GLP-1s (e.g., Ozempic, Wegovy): While not controlled substances, prescribing these for weight loss or diabetes management via telehealth requires a thorough medical evaluation, diagnosis, and treatment plan consistent with the standard of care. Off-label prescribing must be justified and documented.
  • Testosterone/Hormone Therapy: Prescribing controlled substances (e.g., testosterone) for hormone therapy via telehealth is subject to the same Schedule III rules mentioned above. A comprehensive evaluation, including lab work, is essential.
  • Stimulants (e.g., Adderall, Ritalin): These are Schedule II controlled substances. As such, an initial in-person examination is generally required before the first prescription, unless the patient meets one of the specific exceptions for psychiatric disorders, inpatient care, hospice, or nursing home residence. Continued prescribing via telehealth would then be permissible if the practitioner maintains a legitimate medical purpose and relationship.

Compliance with these rules is critical, as violations can lead to severe penalties, including license suspension, fines, and criminal charges.

Florida's scope of practice laws define the services that various healthcare professionals are legally permitted to perform. These laws are critical for understanding delegation, supervision, and independent practice capabilities.

• Nurse Practitioners (NPs): Florida does not grant full practice authority to Nurse Practitioners. NPs in Florida operate under a supervisory or collaborative framework with a physician.

  • Supervision/Collaboration Requirements: NPs must practice under a 'supervision' or 'protocol' agreement with a Florida-licensed physician. This agreement outlines the scope of the NP's practice, the types of services they can provide, and the physician's responsibilities for oversight. While the physician does not need to be physically present, they must be readily available for consultation and regularly review patient charts. Florida Statutes § 464.012 and Rule 64B9-4.001, F.A.C., govern NP practice.
  • Prescribing Authority: NPs can prescribe controlled substances (Schedules II-V) under their supervising physician's protocol, subject to the same limitations as physicians, including PDMP checks. For Schedule II, the supervising physician must also be authorized to prescribe Schedule II drugs.

• Physician Assistants (PAs): PAs in Florida also operate under physician supervision, not independent practice.

  • Supervision Requirements: PAs must be supervised by a Florida-licensed physician. The physician-PA relationship is governed by a 'supervision agreement' or 'protocol' filed with the Board of Medicine or Board of Osteopathic Medicine. This agreement details the PA's duties, the methods of supervision, and the types of medical services the PA is authorized to perform. Florida Statutes § 458.347 (for MDs) and § 459.022 (for DOs) delineate PA practice.
  • Delegation: Physicians can delegate tasks to PAs that are within the PA's scope of practice and the physician's own scope of practice. The physician remains responsible for the PA's actions.
  • Prescribing Authority: PAs can prescribe controlled substances (Schedules II-V) if authorized by their supervising physician and within the supervision agreement, subject to the same limitations as physicians and NPs.

• Other Mid-Level Providers:

  • Certified Registered Nurse Anesthetists (CRNAs): Practice under the supervision of a physician, dentist, or podiatrist.
  • Certified Nurse Midwives (CNMs): Practice under a protocol with a physician.

• Delegation Rules for Medical Assistants (MAs) in Medspas: Medical Assistants in Florida generally have a limited scope of practice focused on administrative and basic clinical support tasks (e.g., taking vital signs, preparing patients for exams). They cannot perform tasks that require independent medical judgment or advanced clinical skills. In medspas, MAs cannot perform procedures such as injections (e.g., Botox, fillers), laser treatments, or IV insertions, as these are considered the practice of medicine or nursing and must be performed by or directly supervised by a licensed physician, PA, or NP within their scope. Delegation of tasks to MAs must be done by a licensed practitioner and must be within the MA's training and competence, and within the delegating practitioner's scope of practice.

• Supervision Requirements: The level of supervision required varies by profession and task. For NPs and PAs, the supervising physician must be readily available for consultation, and regular chart review is typically mandated. Direct, on-site supervision is often required for certain procedures or for new practitioners. For medical procedures in medspas, a physician must be on-site or immediately available, depending on the invasiveness of the procedure and board rules. Rule 64B8-9.018, F.A.C., provides guidance on physician supervision requirements for various personnel and settings.

Navigating Florida's Corporate Practice of Medicine (CPOM) doctrine necessitates careful business structuring, particularly for telehealth companies, medspas, and other healthcare ventures. The PC-MSO model is the predominant compliant structure.

• PC-MSO Structures:

  • When Needed: This model is essential when non-physician investors or entities wish to participate in the financial success of a medical practice without violating CPOM. It separates the clinical decision-making and direct provision of medical services (performed by the Professional Corporation/PC) from the administrative, non-clinical support services (provided by the Management Services Organization/MSO).
  • Professional Corporation (PC) Requirements: The PC (or Professional LLC/PLLC) must be owned entirely by Florida-licensed physicians (or other licensed professionals like dentists for dental practices). This entity directly employs or contracts with the licensed healthcare providers (physicians, NPs, PAs) who deliver patient care. The PC receives all professional fees for medical services.
  • Management Services Organization (MSO): The MSO is typically a traditional corporation (e.g., LLC, C-Corp, S-Corp) that can be owned by non-physicians. The MSO provides a comprehensive suite of administrative and business support services to the PC, such as billing, scheduling, marketing, IT, human resources for non-clinical staff, equipment, and office space.
  • Management Services Agreement (MSA): The relationship between the PC and MSO is governed by a detailed MSA. This agreement is critical for compliance. Key requirements for an MSA in Florida include:
    • Fair Market Value (FMV): All fees paid by the PC to the MSO must be for legitimate services and at fair market value, independent of the volume or value of referrals or services rendered. This is crucial to avoid fee-splitting and anti-kickback violations.
    • No Control Over Clinical Decisions: The MSA must explicitly state that the MSO has no authority or control over the PC's clinical decisions, patient care, or professional judgment.
    • Term and Termination: Clear terms for the agreement's duration and conditions for termination.
    • Services Provided: A detailed list of the specific administrative services the MSO provides.

• Fee-Splitting Rules: Florida Statutes § 456.054 strictly prohibits fee-splitting, which is the division of fees for professional services with any person not licensed to practice the profession, or with any person who has not performed a professional service in the case. This means the MSO cannot receive a percentage of the PC's professional fees. Instead, the MSO's compensation must be a fixed fee, a cost-plus arrangement, or another FMV-based structure that does not fluctuate with the revenue generated by medical services.

• Structuring Ownership for Compliance:

  • Physician Ownership of PC: Ensure all owners of the PC are appropriately licensed in Florida. Verify their licenses are active and in good standing.
  • Separation of Clinical and Administrative: Clearly delineate responsibilities. The PC handles all clinical aspects, while the MSO handles all non-clinical, administrative aspects.
  • Contractual Clarity: All agreements (MSA, employment contracts for providers, etc.) must be meticulously drafted to reflect compliance with CPOM and fee-splitting prohibitions.

• Professional Corporation Requirements: To form a PC in Florida, the incorporators and shareholders must be licensed professionals. The corporate name must typically include 'P.A.' (Professional Association) or 'P.L.L.C.' (Professional Limited Liability Company). The Florida Department of State, Division of Corporations, handles business entity registrations, while the respective professional boards oversee professional licensing and compliance.

Florida's regulatory landscape is continuously evolving, with several key developments and potential changes impacting healthcare companies through 2025-2026.

• Telehealth Expansion and Permanency: While Florida codified many telehealth flexibilities prior to the federal Public Health Emergency (PHE), there continues to be legislative interest in refining and expanding telehealth access. Expect ongoing discussions regarding audio-only telehealth reimbursement parity and further clarification on out-of-state provider registration processes. The state aims to maintain its position as a leader in telehealth adoption.

• Controlled Substance Prescribing Rules (DEA Alignment): The federal Drug Enforcement Administration (DEA) is in the process of finalizing new permanent rules for prescribing controlled substances via telehealth, following the expiration of PHE waivers. Florida's Board of Medicine and Board of Pharmacy will closely monitor these federal changes and may issue updated guidance or amend state rules (e.g., Rule 64B8-9.013, F.A.C.) to ensure alignment or to address any state-specific concerns. Companies should anticipate potential shifts in requirements for initial in-person exams for Schedule II substances.

• Interstate Licensure Compacts: Florida is actively participating in several interstate licensure compacts, which streamline the licensing process for healthcare professionals wishing to practice in multiple states.

  • Interstate Medical Licensure Compact (IMLC): Florida joined the IMLC, allowing eligible physicians to obtain licenses in participating states more efficiently. This significantly benefits telehealth providers seeking to expand their reach.
  • Nurse Licensure Compact (NLC): Florida is a member of the NLC, enabling registered nurses (RNs) and licensed practical nurses (LPNs) to practice in other compact states with a single license.
  • Advanced Practice Registered Nurse (APRN) Compact: Florida has enacted legislation to join the APRN Compact, which would similarly facilitate multi-state practice for NPs and other APRNs once fully implemented.

• Enforcement Trends: The Florida Department of Health and its professional boards continue to focus on enforcing CPOM, fee-splitting prohibitions, and proper supervision of mid-level providers. Recent enforcement actions have targeted entities perceived to be operating as unlicensed medical practices or engaging in improper delegation, particularly within the medspa and wellness clinic sectors. There's also increased scrutiny on deceptive marketing practices and unsubstantiated health claims.

• GLP-1 and Weight Loss Clinic Scrutiny: With the rise in popularity of GLP-1 agonists for weight loss, expect continued regulatory attention on prescribing practices, appropriate patient evaluation, and the prevention of 'pill mill' type operations for these medications. The Boards will likely emphasize the need for comprehensive medical assessments and adherence to evidence-based guidelines.

Companies should regularly monitor updates from the Florida Department of Health, the Board of Medicine, and other relevant professional boards, as well as legislative sessions, to stay abreast of these dynamic changes.

For healthcare companies entering or expanding in Florida, a proactive and meticulous approach to compliance is essential.

• Step-by-Step Compliance Checklist:

  1. Legal Counsel Engagement: Immediately engage Florida-specific healthcare counsel to structure your entity and review all proposed operations.
  2. Entity Formation: Form a compliant Professional Corporation (PC/PLLC) for the clinical arm, owned by Florida-licensed physicians, and a separate Management Services Organization (MSO) for administrative functions.
  3. Licensing: Ensure all individual providers (physicians, NPs, PAs) are actively licensed in Florida. For telehealth, out-of-state providers must register with the Florida DOH.
  4. MSA Development: Draft a robust Management Services Agreement (MSA) between the PC and MSO, ensuring fair market value compensation and explicit separation of clinical control.
  5. Provider Agreements: Develop compliant employment or independent contractor agreements for all clinical staff, ensuring they reflect Florida's scope of practice and supervision rules.
  6. Telehealth Protocols: Establish clear telehealth protocols covering patient evaluation, informed consent, record-keeping, and emergency procedures.
  7. Prescribing Policies: Implement strict policies for controlled substance prescribing, including PDMP checks, Schedule II limitations, and adherence to federal DEA rules.
  8. HIPAA Compliance: Ensure all technology and operational workflows are fully HIPAA compliant.
  9. Advertising Review: Have all marketing and advertising materials reviewed for compliance with Florida's regulations on professional advertising and prohibitions against deceptive practices.
  10. Ongoing Monitoring: Establish an internal compliance program with regular audits and training for staff.

• Common Pitfalls to Avoid:

  • Ignoring CPOM: Assuming a national model is compliant in Florida without specific adaptation.
  • Improper Fee-Splitting: Structuring MSO fees as a percentage of clinical revenue.
  • Lack of Physician Oversight: Allowing non-clinical staff or the MSO to influence clinical decisions or provider compensation based on clinical metrics.
  • Inadequate Supervision: Failing to meet Florida's specific supervision requirements for NPs, PAs, or delegated tasks in medspas.
  • Non-Compliant Controlled Substance Prescribing: Prescribing Schedule II drugs via telehealth without meeting the strict exceptions or failing to utilize the PDMP.
  • Unlicensed Practice: Employing or contracting with providers not properly licensed or registered in Florida.

• Timeline Expectations for Licensing and Setup:

  • Entity Formation (MSO/PC): 2-4 weeks.
  • Individual Provider Licensing (Florida): Can range from 2-6 months, depending on the board and applicant completeness. Interstate compacts can expedite this for eligible providers.
  • Out-of-State Telehealth Provider Registration: Typically 1-3 months.
  • DEA Registration (if needed): 4-6 weeks after state licensure.
  • Credentialing/Enrollment (Payers): 3-6 months.
  • Full Operational Setup: Expect a minimum of 6-9 months for a fully compliant and operational healthcare entity in Florida, assuming no major delays.